NASDAQ: COGT
Cogent Biosciences Inc Stock Ownership - Who owns Cogent Biosciences?

Insider buying vs selling

Have Cogent Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cole PinnowChief Commercial Officer2025-01-1443,750$7.60
$332.41kBuy

1 of 1

COGT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COGT insiders and whales buy or sell their stock.

COGT Shareholders

What type of owners hold Cogent Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC15.00%17,077,329$185.29MInstitution
Kynam Capital Management LP8.00%9,105,000$98.79MInstitution
Paradigm Biocapital Advisors LP7.87%8,963,655$97.26MInstitution
Commodore Capital LP7.81%8,892,816$96.49MInstitution
Blackrock Inc7.18%8,175,527$88.70MInstitution
Tcg Crossover Management LLC6.12%6,964,375$75.56MInstitution
Fairmount Funds Management LLC5.47%6,225,641$67.55MInsider
Fairmount Funds Management LLC5.47%6,225,641$67.55MInstitution
Vanguard Group Inc5.32%6,058,338$65.73MInstitution
Vr Adviser LLC4.99%5,684,411$61.68MInstitution

1 of 3

COGT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COGT90.95%9.05%Net Buying
CVAC3.50%0.00%
MESO0.33%0.00%
LQDA46.17%53.83%Net BuyingNet Selling
ABCL41.78%44.65%Net Buying

Cogent Biosciences Stock Ownership FAQ

Who owns Cogent Biosciences?

Cogent Biosciences (NASDAQ: COGT) is owned by 117.24% institutional shareholders, 11.66% Cogent Biosciences insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Cogent Biosciences shareholder, owning 6.23M shares representing 5.47% of the company. Fairmount Funds Management LLC's Cogent Biosciences shares are currently valued at $68.36M.

If you're new to stock investing, here's how to buy Cogent Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.